Cargando…
Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations
BACKGROUND: Recently, HER2-negative breast cancers have been reclassified by protein expression into ‘HER2-low’ and ‘HER2-zero’ subgroups, but the consideration of HER2-low breast cancer as a distinct biological subtype with differing prognoses remains controversial. By contrast, non-neutral ERBB2 c...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619358/ https://www.ncbi.nlm.nih.gov/pubmed/37920257 http://dx.doi.org/10.1177/17588359231206259 |